The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 02, 2026

Filed:

May. 28, 2021
Applicants:

Dimensiongen, Grand Cayman, KY;

Dimension Genomics Inc, San Diego, CA (US);

Inventors:

Michael David Austin, San Diego, CA (US);

Han Cao, San Diego, CA (US);

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
B01L 3/00 (2006.01); B01F 33/302 (2022.01); B01F 33/3033 (2022.01); B01L 7/00 (2006.01); B33Y 80/00 (2015.01); C12M 1/00 (2006.01); C12M 1/34 (2006.01); C12M 3/00 (2006.01); C12M 3/06 (2006.01); C12Q 1/6848 (2018.01); C12Q 1/686 (2018.01); C12Q 1/6874 (2018.01); G01N 21/29 (2006.01);
U.S. Cl.
CPC ...
B01L 3/50273 (2013.01); C12Q 1/6874 (2013.01); B01L 2300/16 (2013.01);
Abstract

Genome whole chromosome analysis is a critical gold standard method for clinicians to study molecular lesions at single cell level in diseases and cancers. However, they suffer from low-sample-yielding, labor-intensive procedures that require subjective manual involvement of highly trained professionals. Here we disclose new devices, systems, and methods to automate, standardize, and accelerate the digital cytopathological sample and data generation with improved data quality to enable precision medicine and improve clinical practice. This disclosure describes a family of micro-fluidic devices, and accompanying methods for using said devices, to perform cytogenomic analysis on cells, nucleus, vesicles exosomes and their respective chromosomes, chromatins, nucleic acid polymers, subcellular genomic elements and any other dynamic transitional states between these forms. Collectively, these microfluidic devices allow for the consistent physical manipulation and preparation of macromolecules to substantially improve the quality of the of the cytogenetic information being interrogated.


Find Patent Forward Citations

Loading…